ATE2965T1 - Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern. - Google Patents

Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern.

Info

Publication number
ATE2965T1
ATE2965T1 AT80300077T AT80300077T ATE2965T1 AT E2965 T1 ATE2965 T1 AT E2965T1 AT 80300077 T AT80300077 T AT 80300077T AT 80300077 T AT80300077 T AT 80300077T AT E2965 T1 ATE2965 T1 AT E2965T1
Authority
AT
Austria
Prior art keywords
production
methods
antibodies
cell lines
immunogen
Prior art date
Application number
AT80300077T
Other languages
English (en)
Inventor
Giovanni Galfre
Cesar Milstein
Bruce William Wright
Original Assignee
National Research Development Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Research Development Corporation filed Critical National Research Development Corporation
Application granted granted Critical
Publication of ATE2965T1 publication Critical patent/ATE2965T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/91—Cell lines ; Processes using cell lines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Semiconductor Memories (AREA)
  • Static Random-Access Memory (AREA)
  • Internal Circuitry In Semiconductor Integrated Circuit Devices (AREA)
AT80300077T 1979-01-09 1980-01-08 Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern. ATE2965T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB7900775 1979-01-09
EP80300077A EP0014519B1 (de) 1979-01-09 1980-01-08 Zell-Linien, Verfahren zu ihrer Herstellung und Verfahren zur Herstellung von Antikörpern

Publications (1)

Publication Number Publication Date
ATE2965T1 true ATE2965T1 (de) 1983-04-15

Family

ID=10502406

Family Applications (1)

Application Number Title Priority Date Filing Date
AT80300077T ATE2965T1 (de) 1979-01-09 1980-01-08 Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern.

Country Status (11)

Country Link
US (1) US4350683A (de)
EP (1) EP0014519B1 (de)
JP (3) JPS55113722A (de)
AT (1) ATE2965T1 (de)
AU (1) AU542303B2 (de)
CA (1) CA1142466A (de)
DE (1) DE3062558D1 (de)
DK (1) DK169586B1 (de)
GB (1) GB2039948B (de)
IE (1) IE50418B1 (de)
ZA (1) ZA797020B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0043718B1 (de) * 1980-07-07 1984-11-28 National Research Development Corporation Zellinien
EP0044219A1 (de) * 1980-07-16 1982-01-20 Unilever Plc Verfahren zum immunologischen Bestimmen unter Verwendung monoklonaler Antikörper
IL62965A0 (en) * 1980-07-17 1981-07-31 Scripps Miles Lab Inc Monoclonal antibodies to drugs and theri production
US4608337A (en) * 1980-11-07 1986-08-26 The Wistar Institute Human hybridomas and the production of human monoclonal antibodies by human hybridomas
US4722896A (en) * 1981-01-26 1988-02-02 The Beth Israel Hospital Association Method for affinity purification of hybridoma antibodies
JPS58500366A (ja) * 1981-03-06 1983-03-10 セルテツク　リミテツド 単一クロ−ン抗体
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4987079A (en) * 1982-07-06 1991-01-22 Wilbur D. Smith Composition and method for in vitro cell culture
US4517289A (en) * 1982-08-18 1985-05-14 Brigham And Women's Hospital Monoclonal antibodies for human tissue cross-matching
US4950598A (en) * 1982-09-22 1990-08-21 The Board Of Trustees Of The Leland Stanford Junior University Process for making T cell hybridomas
JPS60500864A (ja) * 1983-02-04 1985-06-06 ワドリ、テクナラジズ、インコーパレイティド 近縁関係にあるが別個のタンパク質間に存在する共通決定基に対して特異的なハイブリド−マ抗体の製造および特性づけ
US4508643A (en) * 1983-02-08 1985-04-02 Baxter Travenol Laboratories, Inc. Rat antibody to hCG
GB8318575D0 (en) * 1983-07-08 1983-08-10 Cobbold S P Antibody preparations
US4468346A (en) * 1983-10-27 1984-08-28 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to porcine immunoglobulins
US4469630A (en) * 1983-11-25 1984-09-04 J. T. Baker Chemical Co. Purification of monoclonal antibodies
US4596769A (en) * 1984-03-05 1986-06-24 Temple University Monoclonal antibodies to peptidoglycan and methods of preparing same
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies
JPS60258128A (ja) * 1984-06-06 1985-12-20 Kyowa Hakko Kogyo Co Ltd ラツトモノクロ−ナル抗体
US4791068A (en) * 1984-06-22 1988-12-13 Scripps Clinic And Research Foundation Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators
JPS6179164A (ja) * 1984-09-26 1986-04-22 Amano Pharmaceut Co Ltd 抗原抗体反応の短縮方法
US4757018A (en) * 1985-02-11 1988-07-12 Hazleton Biotechnologies, Inc. Myeloma cell lines and uses thereof
US4814275A (en) * 1985-05-13 1989-03-21 E.I. Dupont De Nemours And Company Monoclonal hybridoma antibody specific for a human epithelial antigen
CA1302919C (en) * 1985-07-03 1992-06-09 Robert T. Buckler Histamine derivatives, immunogen conjugates and antibodies raised thereto
US5292636A (en) * 1986-03-31 1994-03-08 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using soluble T cell surface molecules
DE3787805T2 (de) * 1986-08-04 1994-02-10 Garvan Inst Med Res Serumfreies gewebekulturmedium, das ein polymerzellenschutzmittel enthält.
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
WO1994022915A1 (en) * 1993-03-31 1994-10-13 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
US6610654B2 (en) 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
AU3672800A (en) * 1999-04-09 2000-11-14 Kyowa Hakko Kogyo Co. Ltd. Method for controlling the activity of immunologically functional molecule
EP1229125A4 (de) * 1999-10-19 2005-06-01 Kyowa Hakko Kogyo Kk Verfahren zur herstellung eines polypeptids
US6946292B2 (en) * 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
WO2003084569A1 (en) 2002-04-09 2003-10-16 Kyowa Hakko Kogyo Co., Ltd. Drug containing antibody composition
US7340957B2 (en) 2004-07-29 2008-03-11 Los Alamos National Security, Llc Ultrasonic analyte concentration and application in flow cytometry
WO2006031756A2 (en) 2004-09-10 2006-03-23 Cornell Research Foundation, Inc Betulinol derivatives as anti-cancer agents
US8067175B2 (en) 2005-02-11 2011-11-29 Memorial Sloan-Kettering Cancer Center Methods and compositions for detecting a drug resistant EGFR mutant
US7835000B2 (en) 2006-11-03 2010-11-16 Los Alamos National Security, Llc System and method for measuring particles in a sample stream of a flow cytometer or the like
EP2156178B1 (de) 2007-04-02 2011-12-21 Acoustic Cytometry Systems, Inc. Verfahren zur verbesserten Analyse von in einem akustischen Feld fokussierten Zellen und Partikeln
US7837040B2 (en) * 2007-04-09 2010-11-23 Los Alamos National Security, Llc Acoustic concentration of particles in fluid flow
US8083068B2 (en) 2007-04-09 2011-12-27 Los Alamos National Security, Llc Apparatus for separating particles utilizing engineered acoustic contrast capture particles
US8528406B2 (en) 2007-10-24 2013-09-10 Los Alamos National Security, LLP Method for non-contact particle manipulation and control of particle spacing along an axis
US8263407B2 (en) 2007-10-24 2012-09-11 Los Alamos National Security, Llc Method for non-contact particle manipulation and control of particle spacing along an axis
US8266950B2 (en) 2007-12-19 2012-09-18 Los Alamos National Security, LLP Particle analysis in an acoustic cytometer
US8714014B2 (en) 2008-01-16 2014-05-06 Life Technologies Corporation System and method for acoustic focusing hardware and implementations
US11324222B2 (en) 2016-03-28 2022-05-10 Toyo Seikan Group Holdings, Ltd. Dispersion liquid, method for producing the same, and copper compound particles
JP6984122B2 (ja) * 2016-12-15 2021-12-17 東洋製罐グループホールディングス株式会社 抗ウイルス性を有する分散液

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) * 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
FI64952C (fi) * 1977-06-15 1984-02-10 Wistar Inst Foerfarande foer framstaellning av genetiskt stabila cellinjer
US4172124A (en) * 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies

Also Published As

Publication number Publication date
EP0014519A2 (de) 1980-08-20
AU542303B2 (en) 1985-02-14
IE800032L (en) 1980-07-09
JPH052318B2 (de) 1993-01-12
JPS55113722A (en) 1980-09-02
JPH05276983A (ja) 1993-10-26
AU5445680A (en) 1980-07-17
IE50418B1 (en) 1986-04-16
EP0014519B1 (de) 1983-04-06
JP2648419B2 (ja) 1997-08-27
DK7380A (da) 1980-07-10
CA1142466A (en) 1983-03-08
DE3062558D1 (en) 1983-05-11
DK169586B1 (da) 1994-12-12
GB2039948A (en) 1980-08-20
JPH02227096A (ja) 1990-09-10
EP0014519A3 (en) 1981-01-07
JPH032515B2 (de) 1991-01-16
GB2039948B (en) 1983-04-07
ZA797020B (en) 1981-08-26
US4350683A (en) 1982-09-21

Similar Documents

Publication Publication Date Title
ATE2965T1 (de) Zell-linien, verfahren zu ihrer herstellung und verfahren zur herstellung von antikoerpern.
DE3580654D1 (de) Menschlicher hybridomfusionspartner zur herstellung menschlicher monoklonaler antikoerper.
ATE4778T1 (de) Verfahren zur herstellung von hepatitisvirusantik\rpern und zellstaemme hierfuer.
ATE14023T1 (de) Einen monoklonalen antikoerper produzierende hybridzellinie, antikoerper und verfahren zu seiner herstellung, diesen antikoerper enthaltende therapeutische zusammensetzung und deren diagnostische und therapeutische verwendungen.
ATA208987A (de) Immortalisierte zellinie, verfahren zu ihrer herstellung und verfahren zur herstellung von monoklonalen antikörpern sowie diagnoseverfahren und -mittel
DE3583150D1 (de) Festelektrolytbrennstoffzelle und verfahren zu ihrer herstellung.
EP0176355A3 (de) Immunologisches Verfahren unabhängig von Antigenen
AT368656B (de) Optisch auslesbarer scheibenfoermiger aufzeichnungstraeger, verfahren zu dessen herstellung und vorrichtung zur durchfuehrung dieses verfahrens
ES530853A0 (es) Un metodo para separar una toxina bacteriana de una muestra biologica
DK0451611T3 (da) Human hæmatopoietisk stamcelle
AT369929B (de) Duenne, flexible elektrode und verfahren zu ihrer herstellung und duenne flexible zelle
IE46215L (en) Gamma-globulins, immune nucleic acids and immune dialysates.
PT71814B (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and supressor t cells antibody and methods
AT367243B (de) Batterieseparator und verfahren zu seiner herstellung
GB2000186A (en) Method of producing antibodies in vitro
ATE12660T1 (de) Hybridzellinie zur herstellung monoklonaler antikoerper gegen ein menschliches thymozytantigen, antikoerper und verfahren zu seiner herstellung, diagnostische und therapeutische verwendungen und diesen antikoerper enthaltende pharmazeutische zusammensetzungen.
DE3485128D1 (de) Zellinien verwendbar zur herstellung von hybridomazellen.
PH14144A (en) Process for culturing cells
PT67396B (de) Halogenathyl-sulfone verfahren zu ihrer herstellung sowie ihre verwendung als pllanzenwachstumsregulatoren
DE3783002D1 (de) Neue monoklonale antikoerper gegen ifn-omega, verfahren zu ihrer herstellung und deren verwendung zur reinigung sowie zum nachweis von ifn-omega.
ATE915T1 (de) N,n-dimethyl-o-pyrazolyl-carbaminsaeureester, verfahren zu ihrer herstellung und ihre verwendung als schaedlingsbekaempfungsmittel.
ATE48442T1 (de) Erwachsene-t-zellen-leukaemie verbundene zellinien, verfahren zur herstellung dieser linie und gegenserum.
FI820200A7 (fi) Menetelmä vasta-ainetta tuottavien hybridisolujen ja vasta- aineiden valmistamiseksi, hybridisoluja ja vavasta-aineita.
AU8945482A (en) Antibodies derived from hybrid line from (myeloma + antibody producing cell)
ZA805743B (en) Hybrid cell line for producing monoclonal antibody to human cytotoxic and supressor t cells, antibody, and methods

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
EELA Cancelled due to lapse of time